Physician profile
Narayan P Verma
NPI 1083680235
$21,479.55
in general payments reported to CMS, 2019-2025
45 companies · $848 in 2025
The $848 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $955 · 2020: $6,015 · 2021: $7,692 · 2022: $2,914 · 2023: $1,633 · 2024: $1,422 · 2025: $848.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,360 · Education: $543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,359.96 |
| Education | $543.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $6,929.24 | 2021-2025 | Vraylar, Ubrelvy, Botox |
| Allergan, INC. | $5,696.43 | 2019-2022 | |
| Livanova USA, INC. | $1,668.74 | 2021-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Novartis Pharmaceuticals Corporation | $1,557.09 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $755.79 | 2019-2025 | Austedo Xr, Ajovy, Austedo Xr |
| Biogen, INC. | $748.66 | 2019-2023 | Tysabri, Vumerity |
| Supernus Pharmaceuticals, INC. | $589.49 | 2019-2024 | Qelbree |
| Jazz Pharmaceuticals INC. | $349.96 | 2023-2025 | |
| Harmony Biosciences LLC | $316.25 | 2020-2024 | Wakix |
| Celgene Corporation | $289.02 | 2022-2025 | Zeposia |
| Validus Pharmaceuticals LLC | $258.67 | 2022-2025 | Equetro |
| Eisai INC. | $231.74 | 2020-2024 | |
| Ucb, INC. | $194.47 | 2021-2022 | |
| Genentech USA, INC. | $175.07 | 2019-2025 | Ocrevus, Ocrevus Zunovo |
| Pfizer INC. | $157.92 | 2019-2025 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Narayan Verma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.